Award of CFD's DHA sbir sequential phase II covid-19 pivot medical r & d contract for "producing biosynthetic therapeutics from extreme microbiomes"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH21C0042
Awardee
Awarding agency
Obligated
$1,499,996

Award facts

Opportunity
  • HQ003420R1DSB Solicitation number
Contract value 100% obligated
$1,499,996.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Medical Command Department of the Army, Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Huntsville, AL 35806, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · CFD DHA sbir sequential phase II H2S-0023 producing biosynthetic therapeutics from extreme microbiomes $0
Other Administrative Action P00002 · DHA sbir sequential phase II medical r & d contract for "producing biosynthetic therapeutics from extreme microbiomes" $0
Other Administrative Action P00001 · COR dodaac correction to CFD's DHA sbir sequential phase II medical r & d contract for "producing biosynthetic therapeutics from extreme microbiomes" $0
Original award $1,499,996

About this award

This is a Definitive Contract award under the Small Business Innovation Research (SBIR) program, issued by the U.S. Army's Medical Command (MEDCOM) to CFD Research Corporation, a small business based in Huntsville, Alabama. The $1,499,996.35 contract is for a Sequential Phase II effort titled "Producing Biosynthetic Therapeutics from Extreme Microbiomes" to develop medical R&D related to COVID-19. This award is set aside for small businesses. CFD Research has a history of receiving SBIR and other federal R&D contracts, as well as Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles across the Department of Defense and other agencies to support advanced technology development.

Quick answers

Who was awarded contract W81XWH21C0042?

W81XWH21C0042 was awarded to CFD Research Corporation by Defense Health Agency (Department of Defense) on May 3, 2021.

How much is contract W81XWH21C0042 worth?

The government has obligated $1,499,996 on W81XWH21C0042.

Which agency awarded contract W81XWH21C0042?

Defense Health Agency (Department of Defense) awarded W81XWH21C0042, with funding from Medical Command (Department of the Army).

Was contract W81XWH21C0042 competed?

The extent of competition for W81XWH21C0042 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award